Filing Details
- Accession Number:
- 0001144204-11-063373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-14 06:56:13
- Reporting Period:
- 2011-11-10
- Filing Date:
- 2011-11-14
- Accepted Time:
- 2011-11-14 06:56:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326190 | Pharmathene Inc | PIP | Pharmaceutical Preparations (2834) | 202726770 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1488331 | Richard Thomas Fuerst | C/O Pharmathene Inc One Park Place Suite 450 Annapolis MD 21401 | Evp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2011-11-10 | 10,000 | $1.51 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at $1.5097 (5,000 shares) and $1.5099 (5,000 shares) per share.